Puma Biotechnology Inc (PBYI) — Cash Flow Quality Index
Puma Biotechnology Inc (PBYI) has a Cash Flow Quality Index of 1.22x as of December 2025. Operating cash flow of $14.42 Million exceeds net income of $11.80 Million, indicating high earnings quality where cash backs reported profits. Explore PBYI long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Puma Biotechnology Inc Cash Flow Quality Index (2022–2025)
Historical Cash Flow Quality Index for Puma Biotechnology Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Puma Biotechnology Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Puma Biotechnology Inc (2022–2025)
Year-by-year earnings quality comparison for Puma Biotechnology Inc. For live market cap and the full company financial profile, see Puma Biotechnology Inc (PBYI) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.34x | $41.80 Million | $31.11 Million | ▲ +4.5% |
| 2024 | 1.29x | $38.92 Million | $30.28 Million | ▲ +2.8% |
| 2023 | 1.25x | $27.01 Million | $21.59 Million | ▲ +100.0% |
| 2022 | -7913.50x | $-15.83 Million | $2.00K | — |